{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T02:37:00Z","timestamp":1786847820699,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jneuroim.2013.12.008","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T00:32:39Z","timestamp":1386808359000},"page":"61-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The cytokine and endocannabinoid systems are co-regulated by NF-\u03baB p65\/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients"],"prefix":"10.1016","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9994-433X","authenticated-orcid":false,"given":"Robert B.","family":"Laprairie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan R.","family":"Warford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie E.M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Denovan-Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.12.008_bb0010","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF\u03b1 promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0015","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1073\/pnas.89.5.1875","article-title":"The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression","volume":"89","author":"Ballard","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0020","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/febs.12329","article-title":"In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system","volume":"280","author":"Bari","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorqvist","year":"2008","journal-title":"J. Med. Exp."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Blazquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1189\/jlb.0306224","article-title":"Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids","volume":"81","author":"Borner","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0040","doi-asserted-by":"crossref","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","article-title":"Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease","volume":"32","author":"Bouchard","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbr.2006.02.028","article-title":"Progression deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic rat model","volume":"170","author":"Cao","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0050","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1523\/JNEUROSCI.0116-08.2008","article-title":"Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5\/RANTES) by astrocytes","volume":"28","author":"Chou","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0060","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0169-328X(98)00042-4","article-title":"Acute administration of cocaine, but not amphetamine, increases the level of synaptotagmin IV mRNA in the dorsal striatum of rat","volume":"55","author":"Denovan-Wright","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0075","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","article-title":"Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease","volume":"163","author":"Dowie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0080","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuroscience.2010.06.056","article-title":"Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice","volume":"170","author":"Dowie","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0085","doi-asserted-by":"crossref","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington's disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","article-title":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease","volume":"45","author":"Franciosi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0095","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1471-4159.2008.05823.x","article-title":"Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction","volume":"108","author":"Gadavarthi","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0100","doi-asserted-by":"crossref","first-page":"e23837","DOI":"10.1371\/journal.pone.0023837","article-title":"Regulation of miR-146a by RelA\/NFkB and p53 in STHdh(Q111)\/Hdh(Q111) cells, a cell model of Huntington's disease","volume":"6","author":"Ghose","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0115","doi-asserted-by":"crossref","first-page":"e41152","DOI":"10.1371\/journal.pone.0041152","article-title":"Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression","volume":"7","author":"Hogel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuropharm.2013.04.006","article-title":"Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease","volume":"72","author":"Laprairie","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0125","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1093\/hmg\/ddq358","article-title":"The Huntington's disease mutation impairs Huntingtin's role in the transport of NF-\u03baB from the synapse to the nucleus","volume":"19","author":"Marcora","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0130","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0135","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","article-title":"Worsening of Huntington disease phenotype in CB1 receptor knockout mice","volume":"42","author":"Mievis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0140","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/pr.110.003491","article-title":"The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications","volume":"63","author":"Miller","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0145","doi-asserted-by":"crossref","first-page":"19002","DOI":"10.1074\/jbc.M109.068460","article-title":"Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma","volume":"285","author":"Mukhopadhyay","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0150","doi-asserted-by":"crossref","first-page":"RRN1190","DOI":"10.1371\/currents.RRN1190","article-title":"Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington's disease","volume":"2","author":"Nguyen","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0155","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.yexcr.2009.06.017","article-title":"Chemokines released from astrocytes promote chemokine receptor 5-mediated neuronal cell differentiation","volume":"315","author":"Park","year":"2009","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0160","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jcp.22727","article-title":"Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth","volume":"227","author":"Proto","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bjp.0707569","article-title":"CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration","volume":"153","author":"Rajesh","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0170","doi-asserted-by":"crossref","first-page":"e14311","DOI":"10.1371\/journal.pone.0014311","article-title":"Transcriptional activation of REST by Sp1 in Huntington's disease models","volume":"5","author":"Ravache","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0175","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"Silverstoni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(93)91209-B","article-title":"Acidic and basic fibroblast growth factor-like immunoreactivity in the striatum and midbrain in Huntington's disease","volume":"610","author":"Tooyama","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0185","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0190","doi-asserted-by":"crossref","first-page":"RRN1231","DOI":"10.1371\/currents.RRN1231","article-title":"Abnormal peripheral chemokine profile in Huntington's disease","volume":"3","author":"Wild","year":"2011","journal-title":"PLoS Curr."},{"key":"10.1016\/j.jneuroim.2013.12.008_bb0195","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813003391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813003391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:21:39Z","timestamp":1759047699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813003391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0165572813003391"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.12.008","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cytokine and endocannabinoid systems are co-regulated by NF-\u03baB p65\/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}